Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nodal radiotherapy for prostate adenocarcinoma recurrence: predictive factors for efficacy.
Gueiderikh A, Baude J, Baron D, Schiappa R, Katsahian S, Moreau D, Laurans M, Bibault JE, Kreps S, Bondiau PY, Quivrin M, Lépinoy A, Pasquier D, Hannoun-Levi JM, Giraud P. Gueiderikh A, et al. Among authors: baron d. Front Oncol. 2024 Oct 25;14:1468248. doi: 10.3389/fonc.2024.1468248. eCollection 2024. Front Oncol. 2024. PMID: 39525616 Free PMC article.
Response to "Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients - A closer inspection will improve your vision".
Baron D, Pasquier D, Pace-Loscos T, Vandendorpe B, Schiappa R, Ortholan C, Hannoun-Levi JM. Baron D, et al. Clin Transl Radiat Oncol. 2024 Feb 21;46:100755. doi: 10.1016/j.ctro.2024.100755. eCollection 2024 May. Clin Transl Radiat Oncol. 2024. PMID: 38440793 Free PMC article. No abstract available.
A phase III randomised trial on the addition of a contact X-ray brachytherapy boost to standard neoadjuvant chemo-radiotherapy for organ preservation in early rectal adenocarcinoma: 5 year results of the OPERA trial.
Baron D, Pace Loscos T, Schiappa R, Barbet N, Dost E, Ben Dhia S, Soltani S, Mineur L, Martel I, Horn S, Picardi C, Stewart A, Cotte E, Coquard R, Baudin G, Evesque L, Dhadda A, Sun Myint A, Gérard JP, Doyen J; ICONE group. Baron D, et al. Ann Oncol. 2024 Nov 10:S0923-7534(24)04904-4. doi: 10.1016/j.annonc.2024.10.827. Online ahead of print. Ann Oncol. 2024. PMID: 39532203
'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.
Mitrea D, Barbet N, Pacé-Loscos T, Scouarnec C, Ben-Dhia S, Baron D, Mineur L, Évesque L, Durand-Labrunie J, Gérard JP, Baudin G, Doyen J. Mitrea D, et al. Among authors: baron d. Cancer Radiother. 2024 Aug;28(4):323-332. doi: 10.1016/j.canrad.2024.02.003. Epub 2024 Jul 14. Cancer Radiother. 2024. PMID: 39003168
883 results